Xerdoxo
On the Bulgarian pack: Ксердоксо 2,5 mg филмирани таблетки
2.5 mg film-coated tablets 100 · film - coated tablets
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Rivaroxaban
- Used in
- Blood, clotting and anaemia
- Made by
- KRKA, d.d., Novo mesto
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (rivaroxaban). It describes the substance, not this Bulgarian product — its uses and doses can differ.
XARELTO is a selective inhibitor of FXa.
It does not require a cofactor (such as Anti-thrombin III) for activity.
Unchanged drug is excreted into urine, mainly via active tubular secretion and to a lesser extent via glomerular filtration (approximate 5:1 ratio).
For the 2.5 mg and 10 mg dose, it is estimated to be 80% to 100% and is not affected by food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-10
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (rivaroxaban). It describes the substance, not this Bulgarian product — its uses and doses can differ.
WARNING: (A) PREMATURE DISCONTINUATION OF XARELTO INCREASES THE RISK OF THROMBOTIC EVENTS, (B) SPINAL/EPIDURAL HEMATOMA A.
- XARELTO is contraindicated in patients with: active pathological bleeding [see Warnings and Precautions (5.2) ] severe hypersensitivity reaction to XARELTO (e.g., anaphylactic reactions) [see Adverse Reactions (6.2) ] Active pathological bleeding ( 4 ) Severe hypersensitivity reaction to XARELTO ( 4 )
The most common adverse reactions with XARELTO were bleeding complications [see Warnings and Precautions (5.2) ].
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | KRKA, d.d., Novo mesto · Slovenia |
|---|---|
| Active substance | Rivaroxaban |
| Used in | Blood, clotting and anaemia |
| Strength | 2.5 mg film-coated tablets 100 |
| Form | film - coated tablets |
| Pack sizes | 100 |
| Classification | B01AF01 · Blood, clotting and anaemia |
| Name in the register | Ксердоксо 2,5 mg филмирани таблетки |
| Reg. no. | 20200083 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
24 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- film - coated tablets24 products
- 2.5 mg film-coated tablets 100
- 2.5 mg
- 2.5 mg film-coated tablets 30
- 2.5 mg film-coated tablets 90
- 2.5 mg film-coated tablets 60
- 2.5 mg film-coated tablets 10
- 10 mg
- 10 mg film-coated tablets 10
- 10 mg film-coated tablets 60
- 10 mg film-coated tablets 100
- 10 mg film-coated tablets 90
- 10 mg film-coated tablets 30
- 15 mg
- 15 mg film-coated tablets 10
- 15 mg film-coated tablets 60
- 15 mg film-coated tablets 100
- 15 mg film-coated tablets 90
- 15 mg film-coated tablets 30
- 20 mg
- 20 mg film-coated tablets 10
- 20 mg film-coated tablets 60
- 20 mg film-coated tablets 100
- 20 mg film-coated tablets 90
- 20 mg film-coated tablets 30
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.